An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

Ireland's answer to The Real Housewives franchise might have been a flash in the pan but our ladies still managed to serve up ...

Glioblastoma (GBM), an aggressive form of cancer that grows in the brain or spinal cord, occurs at an incidence rate of about 3/100,000 persons in the Unit | Cancer ...

A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...

New research suggests that electrical spinal cord stimulation could improve muscle function for patients who have spinal ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

Researchers reported what they called the first evidence that a spine-stimulating implant might aid neurodegenerative ...

The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 metres.